Biotech & AI
Enveda Raises $311M Series E to Accelerate Nature-Derived AI Drug Trials
Enveda's $311 million Series E funding fuels AI-powered discovery of plant-based medicines and moves multiple candidates into human trials.
ai-drug-discovery
1 story